© 2026 GlobalCapital, Derivia Intelligence Limited, company number 15235970, 4 Bouverie Street, London, EC4Y 8AX. Part of the Delinian group. All rights reserved.

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement | Event Participant Terms & Conditions | Cookies

SRI

Top section

Top section

France's new €8bn 30 year grabs record demand, performs in secondary

◆ AFT's Antoine Deruennes says 'clear message' showed demand for 30 year ◆ Speedy execution before US employment data ◆ Green OAT syndication next
Deal will bring fourth major multilateral development bank to the market

Fidelidade offers rare Portugese insurance tier two

◆ Refi deal came as issuer prepares IPO ◆ Deal extends the insurer's tier two curve by 10 years ◆ 'Strong bid' for Iberian FIG credit, says rival banker

REN runs into euros with tight EuGB deal

◆ Portuguese utility firm powers up EuGB curve ◆ Sub-benchmark trade's book proves sticky ◆ Deal lands through fair value
Deal will bring fourth major multilateral development bank to the market
Sub-sections
  • Chinese state-owned company Genertec Universal Medical Group has returned to the loan market to syndicate a $700m-equivalent deal.
  • WuXi Biologics Holdings has raised HK$11.5bn ($1.49bn) after increasing a sale of shares in subsidiary WuXi Biologics (Cayman).
  • SSA
    Kenneth Lay, chair of the International Finance Facility for Immunisation (IFFIm), is no stranger to using financial innovation to help tackle some of the world's biggest problems. He spoke to GlobalCapital about the importance of IFFIm as a vehicle to finance the global vaccine rollout in the fight against the coronavirus pandemic.